GLOBALFOUNDRIES enters September under pressure, down 12% over the past month to $43.93, as fresh analyst coverage lands well below consensus and options market participants have turned markedly more defensive.
The most immediate catalyst is on the Street. Stifel initiated coverage on September 2 with a Buy rating but set a $60 target — a full $16 below the current analyst consensus mean of $76, and less than 37% above where the stock is trading now. That cautious entry point matters. TD Cowen, maintaining Buy, trimmed its target from $85 to $75 after the August 5 earnings release. UBS held Neutral and cut from $61 to $55. The direction of travel from active analysts this month has been uniformly lower, even among bulls. Broader consensus remains constructive at 10 Buy-equivalent ratings, and the analyst recommendation differential factor scores in the 87th percentile — but the targets are compressing toward the stock, not the other way around.
Options positioning reflects the same defensive shift. The put/call ratio has climbed to 1.27, running above its 20-day average of 1.09 — roughly one standard deviation elevated, and sustained at those levels for over a week. The PCR has held above 1.25 every session since August 24, a stretch that coincides almost exactly with the stock's sharpest leg lower this month. Downside protection is being bought, not sold. The 52-week high on the PCR is 1.63, so this isn't panic — but it's clearly more defensive than the mid-August reading around 0.91.
Short interest, by contrast, tells a much calmer story. Bears have actually been retreating. Short interest has fallen 18.5% over the past week and 22.5% over the past month, settling at just under 1% of the free float — comfortably low. Borrow availability is extremely loose at roughly 1,790%, meaning there are approximately 18 shares available for every one already borrowed. Cost to borrow is negligible at 0.40%. This is not a stock where short sellers are pressing an aggressive thesis — the lending market is wide open and positioning is light.
The ownership picture adds important context to the whole setup. Abu Dhabi's Mubadala Investment Company controls 72.8% of shares, a stake it trimmed modestly in its latest disclosed filing from 77.1% to 72.8%. FMR (Fidelity) moved the other direction, filing a 13G/A in August showing its stake has grown from 11.5% to 12.7%. Neither filing carries 13D activist intent, and the disclosure caveat applies — these positions are as last reported, and Mubadala's dominant stake means the public float is genuinely narrow. Insider activity over the past 90 days has been limited to small planned sales by the Chief Legal Officer under a 10b5-1 arrangement and routine tax-withholding transactions — no open-market buying or selling of note.
On valuation, the stock trades at roughly 19.4x trailing earnings and 8.6x EV/EBITDA. Both multiples have eased 30-day, with the P/E contracting around 1.5 turns and EV/EBITDA up only modestly. The ORTEX short score has drifted lower to 33.9 from 36.9 two weeks ago, consistent with the falling short interest. The bull case rests on Silicon Photonics, Physical AI, and the company's mature-node specialisation; bears point to margin pressure, constrained capacity for specialised customers, and rising domestic Chinese competition in foundry.
The next scheduled earnings date is November 10 — the last two prints produced modest negative day-one reactions of around 1-3%, followed by recovery over the following week. Between now and then, the Stifel initiation and where other analysts anchor their revised targets relative to that $60 floor will be the clearest signal of whether the Street's view is genuinely compressing or simply adjusting to a stock that has re-rated lower.
See the live data behind this article on ORTEX.
Open GFS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
